Characterisation of nanomaterials towards safe and efficient nanodrugs. Working Group 2. OnLine Conference. June 22–23, 2021. Book of Abstracts

dc.contributor.editor	Vinković Vrček, Ivana
dc.contributor.editor	Apartsin, Evgeny
dc.date.accessioned	2021-07-02T06:46:42Z
dc.date.available	2021-07-02T06:46:42Z
dc.date.issued	2021
dc.identifier.uri	http://hdl.handle.net/11089/37891
dc.description	Zagreb, Croatia: Toulouse, France; Lodz, Poland; June 22–23, 2021	pl_PL
dc.description.sponsorship	This Book of Abstract is based upon Working Group 2 Online Conference of COST Action 17140 „Cancer nanomedicine - from the bench to the bedside“ Nano2Clinic, supported by COST (European Cooperation in Science and Technology). COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.	pl_PL
dc.language.iso	pl	pl_PL
dc.publisher	COST Action CA17140 (Nano2Clinic)	pl_PL
dc.rights	Uznanie autorstwa 4.0 Międzynarodowe	*
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/	*
dc.title	Characterisation of nanomaterials towards safe and efficient nanodrugs. Working Group 2. OnLine Conference. June 22–23, 2021. Book of Abstracts	pl_PL
dc.type	Book	pl_PL
dc.page.number	100	pl_PL
dc.identifier.doi	https://doi.org/10.18778/BOA
dc.discipline	nauki biologiczne	pl_PL

Poza zaznaczonymi wyjątkami, licencja tej pozycji opisana jest jako Uznanie autorstwa 4.0 Międzynarodowe